Compare · CDIO vs NNNN
CDIO vs NNNN
Side-by-side comparison of Cardio Diagnostics Holdings Inc. (CDIO) and Anbio Biotechnology (NNNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDIO and NNNN operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- NNNN is the larger of the two at $2.48B, about 420.7x CDIO ($5.9M).
- Over the past year, CDIO is down 58.9% and NNNN is up 111.7% - NNNN leads by 170.6 points.
- CDIO has been more active in the news (2 items in the past 4 weeks vs 1 for NNNN).
PerformanceCDIO-58.91%NNNN+111.73%
2025-06-09+0.00%2026-06-08
- Company
- Cardio Diagnostics Holdings Inc.
- Anbio Biotechnology
- Price
- $1.96-0.51%
- $18.23-34.52%
- Market cap
- $5.9M
- $2.48B
- 1M return
- +7.69%
- -30.41%
- 1Y return
- -58.91%
- +111.73%
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2025
- News (4w)
- 2
- 1
- Recent ratings
- 0
- 0
Latest CDIO
- Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.
- SEC Form 10-Q filed by Cardio Diagnostics Holdings Inc.
- IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.
- SEC Form 4 filed by Fung Peter K
- SEC Form 4 filed by Betts Wendy J
- SEC Form 4 filed by Intrater James
- SEC Form 4 filed by Burton Paul Frederick
- SEC Form 10-K filed by Cardio Diagnostics Holdings Inc.
- Cardio Diagnostics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest NNNN
- SEC Form 6-K filed by Anbio Biotechnology
- SEC Form 6-K filed by Anbio Biotechnology
- Amendment: SEC Form 20-F/A filed by Anbio Biotechnology
- SEC Form 3 filed by new insider Song Suki
- SEC Form 3 filed by new insider Hartzler Nancy
- SEC Form 3 filed by new insider Lau Michael
- SEC Form 3 filed by new insider Tian Chris
- SEC Form 3 filed by new insider Xu Cany
- SEC Form 20-F filed by Anbio Biotechnology
- Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum